Powered by BiozThis cell line is a modified version of DF19-9-7T, engineered to contain CloverGFP and a puromycin resistance gene driven by the EF1a promoter. Ubiquitous and stable GFP expression clones were selected with puromycin selection. This cell line maintains constitutive expression of GFP.
- Unit of Measure (UOM) vial
- Cell Type Modified Human iPS
- Sex Male
- Reprogramming Method Non-Integrating (Episomal plasmid: pEP4EO2SET2K (OCT4/SOX2/LT/KLF4), pEP4EO2SEN2K (OCT4/SOX2/NANOG/KLF4), and pCEP4-M2L (MYC/LIN28) plasmids)
- Genetic Modification Keyword Reporter; Constitutive
- Disease None reported
- Pubmed Abstract Kang, Hyunjun, et al "CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus." Molecular Therapy Nucleic Acids,vol. 4 (2015), doi:10.1038/mtna.2015.42.
- Provider University of Wisconsin - Dr. Igor Slukvin
- Collections Uncategorized
| Lot Number | Culture Platform | Lot Description | Banked By | Passage Number | Protocol | Product Info URL |
| WB66670 | mTeSR1/Matrigel | WiCell | 46 | WiCell Feeder Independent Pluripotent Stem Cell Protocol |